HEALTH CARE WARS:
NOVEMBER 2025 DASHBOARD
THE IDEOLOGICAL THEATER
Archive
HHS Influencers' focus on "Big Food" and "Big Pharma" (X data)
Notable new X followings
NIH Director Jay Bhattacharya
- Dmitry Abramov:
Cardiologist whose study on cardiovascular disease was praised recently by Director Bhattacharya - Genevieve Jurvetson:
Board member of the Psychedelic Science Funders Collaborative; wife of venture capitalist Steve Jurvetson - Victor Pereira-Sanchez:
Spanish psychiatrist with a perspective grounded in his Catholic faith - Brandon M Showalter:
Journalist at The Christian Post who writes about "bioethics issues"
Deputy HHS Secretary Jim O'Neill
- Jason Locasale, PhD:
Scientist studying metabolism's role in cancer; critic of academia (followed by Director Bhattacharya last month) - OpenVAERS:
Website publishing VAERS data and making it more "user friendly"
Calley Means
- Billy Evans:
CEO of a startup "developing the first AI-native sensors for health"; partner of Theranos founder Elizabeth Holmes - Bret Scher, MD:
Medical director of Metabolic Mind and the Baszucki Group; keto advocate who believes medical school "frequently... undervalues metabolic health"
New Trump Administration hires and nominees
| Hire | Background | Pharma Perspectives | Food Perspectives |
|---|---|---|---|
| Dr. Steven Kozlowski, Chief Scientist, FDA | Pharmaceutical researcher with over 30 years of experience at FDA; held senior roles at the Center for Drug Evaluation and Research (2003-2024)[1] | Previously led the FDA team “responsible for… the quality of all active ingredients” in products “from over-the-counter analgesics to complex biological products”[2] | N/A |
| Dr. Anthony Letai, Director of the National Cancer Institute, NIH | Former Harvard Medical School professor, oncologist at the Dana-Farber Cancer Institute, and co-founder of the Society for Functional Precision Medicine[3] | Conducted "pioneering work in functional precision oncology" to develop "drugs that are now standard treatment for many adults with leukemia"[4] | N/A |
Health care op-eds published in The New York Times, The Wall Street Journal, and The Washington Post
THE COMMERCIAL THEATER
Top health care ad spenders on Meta Platforms
Corporate sponsors of health care conferences and "fly-ins"
Association of Cancer Care Centers National Oncology Conference (October 15–17)[5]
Gold: Amgen, Bristol Myers Squibb, and LeanTaaS
Silver: Azra AI, McKesson, OncoLens, Quest Diagnostics, and VieCure
Bronze: AbbVie, Agios, CMM Global, Constant Media, Deciphera, Ecopharm, Fennec Pharma, Guardant, Natera, Patient Resource Navigator, Protocol Behavioral Health, Radiation Business Solutions, Registry Partners, RGCC, Rigel, RxVantage, Tempus, The Insighters, Thynk Health, Sobi, and Yunu
Sickle Cell Disease Association of America 2025 Annual National Convention (October 15–18)[6]
Legacy: Pfizer
Diamond: Novo Nordisk
Platinum: Agios and Vertex
Gold: CVS Health, Fulcrum Therapeutics, and Genetix Biotherapeutics
Silver: Beam Therapeutics, Chiesi, CSL, and Sanofi
AAO 2025 – American Academy of Ophthalmology (October 17–20)[7]
Platinum: Genentech and Regeneron
Gold: AbbVie
Silver: Merck
National Community Pharmacists Association 2025 Annual Convention (October 18–21)[8]
American Associated Pharmacies, AAPA, Affiniti, AlignRx, Anda, American Pharmacy Cooperative, AstraZeneca, BASSAGEL, Cardinal Health, Compliant Pharmacy Alliance Cooperative, GeriMed, Independent Pharmacy Cooperative, Legally Mine, Liberty Software, Lilly, Live Oak Bank, McKesson, Merck, NCPDP, Nimble, Noritsu Pharmacy Automation, Olympia Pharmaceuticals, PBA Health, PCCA, Pfizer, Pharmaceutical Printed Literature Association, Pharmacists Mutual, PioneerRx | RedSail Technologies, PPOk, Prasco, Prescryptive, RxTechExam, SubMagna, Surescripts, WSPC, and Yaral Pharma
Newsletter sponsors
Axios (Vitals)
Politico – Health Care
(Pulse and Prescription Pulse)
Politico – Food/Ag
(Weekly Agriculture)
STAT News
(D.C. Diagnosis and
Morning Rounds)
- “Steven Kozlowski M.D.,” Food and Drug Administration, https://www.fda.gov/about-fda/fda-organization/steven-kozlowski; and Steven Kozlowski, LinkedIn, https://www.linkedin.com/in/steven-kozlowski-881023107.
- Ibid.
- “NCI Director Dr. Anthony Letai,” National Institutes of Health, https://www.cancer.gov/about-nci/leadership/director; and “About Us,” Society for Functional Precision Medicine, https://www.sfpm.io/about.
- “NCI Director Dr. Anthony Letai,” ibid.
- "NOC Sponsors," National Oncology Conference, https://registration.accc-cancer.org/42nd-national-oncology-conference/page/5016752/noc-sponsors.
- "Annual National Convention," Sickle Cell Disease Association of America, https://www.sicklecelldisease.org/get-involved/events/annual-national-convention.
- "Unrestricted Meeting Support," American Academy of Ophthalmology, https://www.aao.org/annual-meeting/support.
- "Thank you to our 2025 sponsors," National Community Pharmacists Association, https://ncpa.org/annual-convention.
About Baron
Baron has guided clients for nearly two decades through the most challenging political terrain. Applying a methodology focused on mastering the strategic competition of interests, Baron advises some of the nation's most prominent organizations, including members of the Fortune 10, several of America's largest privately held businesses, and the U.S. Department of Defense. Baron's health care sector clients have included insurers and pharmacy benefit managers, integrated health systems, and medical device firms.
© 2025 Baron Public Affairs, LLC. All Rights Reserved. No part of these materials may be reproduced or transmitted in any form or by any means, electronic or mechanical, including but not limited to photocopy, recording, or any other information storage or retrieval system known now or in the future, without the express written permission of Baron Public Affairs, LLC. These materials do not constitute advice on any particular investment or commercial issue or matter. No part of this work constitutes investment or legal advice and is not to be relied upon as such. The unauthorized reproduction or distribution of this copyrighted work is illegal and may result in civil or criminal penalties under the U.S. Copyright Act and applicable copyright law.
